@article{30687, keywords = {Stigma, Social Justice, Tuberculosis, Treatment, Multidrug-resistant tuberculosis (MDR-TB), Economic evaluation, Ethics, Human Rights}, author = {Zwerling A and Dowdy D and Delft A and Taylor H and Merritt M W}, title = {Incorporating social justice and stigma in cost-effectiveness analysis: drug-resistant tuberculosis treatment.}, abstract = {

Novel therapies for multidrug-resistant tuberculosis (MDR-TB) are likely to be expensive. The cost of novel drugs (e.g., bedaquiline, delamanid) may be so prohibitively high that a traditional cost-effectiveness analysis (CEA) would rate regimens containing these drugs as not cost-effective. Traditional CEA may not appropriately account for considerations of social justice, and may put the most disadvantaged populations at greater risk. Using the example of novel drug regimens for MDR-TB, we propose a novel methodology, {\textquoteright}justice-enhanced CEA{\textquoteright}, and demonstrate how such an approach can simultaneously assess social justice impacts alongside traditional cost-effectiveness ratios. Justice-enhanced CEA, as we envision it, is performed in three steps: 1) systematic data collection about patients{\textquoteright} lived experiences, 2) use of empirical findings to inform social justice assessments, and 3) incorporation of data-informed social justice assessments into a decision analytic framework that includes traditional CEA. These components are organized around a core framework of social justice developed by Bailey et al. to compare impacts on disadvantage not otherwise captured by CEA. Formal social justice assessments can produce three composite levels: {\textquoteright}expected not to worsen{\textellipsis}{\textquoteright}, {\textquoteright}may worsen{\textellipsis}{\textquoteright}, and {\textquoteright}expected to worsen clustering of disadvantage{\textquoteright}. Levels of social justice impact would be assessed for each major type of outcome under each policy scenario compared. Social justice assessments are then overlaid side-by-side with cost-effectiveness assessments corresponding to each branch pathway on the decision tree. In conclusion, we present a {\textquoteright}justice-enhanced{\textquoteright} framework that enables the incorporation of social justice concerns into traditional CEA for the evaluation of new regimens for MDR-TB.

}, year = {2017}, journal = {The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease}, volume = {21}, pages = {69-74}, issn = {1815-7920}, url = {http://tinyurl.com/yaxor9mj}, doi = {10.5588/ijtld.16.0839}, language = {eng}, }